Consolidated Balance Sheet - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 64,419	$ 12,913
Advances to Suppliers		10,830
Other receivable	150,000
Inventories	160,492	245,776
Total current assets	374,911	269,519
Fixed assets, net	24,110	31,337
Derivative Valuation allowance
Investment in equity method investee	100	100
TOTAL ASSETS	399,121	300,956
Current liabilities
Accounts payable and accrued liabilities	319,618	206,873
Due to related parties	164,946	45,000
Convertible notes payable, net of discount	988,800	1,865,000
Derivative liability	72,487	2,286,014
Settlement liability
Current liabilities of discontinued operations
Total current liabilities	1,545,851	4,402,887
Total liabilities	1,545,851	4,402,887
Stockholders’ deficit
Preferred Stock Value
Common stock; $0.0001 par value; 200,000,000 shares authorized; 75,437,604 and 45,046,637 shares issued and outstanding as of December 31, 2022 and December 31, 2021 , respectively.	7,544	4,504
Stock subscription receivable	(261,059)
Additional paid-in capital	24,427,009	21,867,416
Accumulated deficit	(25,320,424)	(25,974,051)
Total Stockholders’ deficit	(1,146,730)	(4,101,931)
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY	399,121	300,956
Series B Preferred Stock [Member]
Stockholders’ deficit
Preferred Stock Value
Series C Preferred Stock [Member]
Stockholders’ deficit
Preferred Stock Value	$ 200	$ 200